The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

480

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Biliary Tract Cancer (BTC)
Interventions
GENETIC

next-generation sequencing

Tumor tissue will be collected from advanced BTC patients for real-time next-generation sequencing analysis

Trial Locations (13)

Unknown

Chang Gung Memorial Hospital, Chiayi, Chiayi City

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital,, Kaohsiung City

China Medical University Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

Koo Foundation Sun Yat-Sen Cancer Center, Taipei

MacKay Memorial Hospital, Taipei

National Taiwan University Hospital, Taipei

Taipei Medical University-Shuang Ho Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Tri-Service General Hospital, Taipei

Linko Chang Gung Memorial Hospital, Taoyuan District

Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan District

All Listed Sponsors
collaborator

National Taiwan University Hospital

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

Tri-Service General Hospital

OTHER

collaborator

Chang Gung Medical Foundation (Linkou Branch)

UNKNOWN

collaborator

Taipei Medical University Shuang Ho Hospital

OTHER

collaborator

Koo Foundation Sun Yat-Sen Cancer Center

OTHER

collaborator

China Medical University Hospital

OTHER

collaborator

National Cheng-Kung University Hospital

OTHER

collaborator

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

Chang Gung Memorial Hospital, Chiayi

UNKNOWN

collaborator

Taoyuan General Hospital, Ministry of Health and Welfare

UNKNOWN

collaborator

Mackay Memorial Hospital

OTHER

lead

National Health Research Institutes, Taiwan

OTHER